Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMPT: Romiplostim vs. rhTPO for Platelet Engraftment After Allo-HSCT
NCT07400341Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in myelodysplastic syndrome (MDS), aplastic anemia, sponsored by First Affiliated Hospital of Soochow University. Started Jan 2026; status: recruiting.
02
Drugs
romiplostim
03
Conditions
myelodysplastic syndrome (MDS)aplastic anemia
Beyond the preview
Go deeper on NCT07400341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07400341.